IN RE MIRAPEX PRODUCTS LIABILITY LITIGATION

No. 17-2204.

912 F.3d 1129 (2019)

IN RE: MIRAPEX PRODUCTS LIABILITY LITIGATION. Marc Mancini Plaintiff-Appellant v. Boehringer Ingelheim Pharmaceuticals, Inc., et al. Defendants-Appellees.

United States Court of Appeals, Eighth Circuit.

Filed: January 10, 2019.


Attorney(s) appearing for the Case

Counsel who represented the appellant was Will D. Nefzger of Louisville, KY.

Counsel who represented the appellee were Tracy Joan Van Steenburgh and Scott A. Smith, of Minneapolis, MN., Lori B. Leskin, of New York, NY., and Jason Charles Rose of Baltimore, MD.

Before SMITH, Chief Judge, LOKEN and GRUENDER, Circuit Judges.


Mirapex is a dopamine agonist that is FDA-approved for treating adults with Parkinson's disease and movement disorders. On December 30, 2010, Marc Mancini filed this action against the defendant pharmaceutical companies, alleging they are liable for substantial gambling and other financial losses that resulted from obsessive...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases